Glaucoma is a group of diseases that can damage the eye’s optic nerve and result in vision loss and blindness. Glaucoma is often called ‘the sneak thief of sight’ because there are usually no warning signs or symptoms until noticeable vision loss. Early diagnosis and treatment is crucial in protecting your eyes against serious vision loss.
Once diagnosed with glaucoma, our doctors may prescribe medications to reduce intraocular pressure and prevent damage to the optic nerve. Depending on the type and severity of the patient’s glaucoma, our doctors may recommend laser surgery. Surgery can help lower intraocular pressure of the eye when medication is not sufficient.
Our board-certified ophthalmologists are highly qualified to diagnose, monitor and treat glaucoma patients utilizing the most advanced medical, laser and/or surgical procedures available.
Your Once-In-A-Lifetime Opportunity to Have Your Glaucoma & Cataracts Addressed at the Same Time
If you’ve been managing your glaucoma symptoms with medication, and now are preparing for cataract surgery, iStent® may be an ideal option for you. iStent® is a tiny implant that’s helped thousands of people with glaucoma successfully manage their intraocular pressure. By taking advantage of this once-in-a-lifetime opportunity during cataract surgery, you can help address both of these conditions at the same time.
The Kahook Dual Blade (KDB) is an elegant, single-use, ophthalmic blade
It makes parallel incisions in the trabecular meshwork (TM) and inner wall of the Canal of Schlemm.
The device has a micro-engineered profile which allows for insertion into the eye through a clear cornea micro-incision. The surgical grade stainless steel body is comprised of a long, thin shaft that allows for access across the anterior chamber, a pointed tip used to pierce TM under gonioscopic view, a ramp that lifts and stretches the tissue as the device is advanced, and two blades precision manufactured through laser cutting technology to produce
simultaneous incisions in treated tissues.
Ivantis has developed the Hydrus® Microstent, the world’s first “intracanalicular scaffold” for the treatment of primary open angle glaucoma (POAG). The Hydrus procedure is designed to be less invasive than traditional glaucoma surgery and can be performed during cataract surgery using the same microsurgical incisions. Roughly the size of an eyelash, the Hydrus Microstent is made from a super-elastic, biocompatible alloy (nitinol®), which is a well-proven biomaterial used in over 1 million implants in a variety of medical devices to date.